|
|
|
Insider
Information: |
Aselage Steve |
Relationship: |
Director |
City: |
Fremont |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
293,421 |
|
Indirect Shares
|
22,000 |
|
|
Direct
Value |
$6,921,325 |
|
|
Indirect Value
|
$157,085 |
|
|
Total
Shares |
315,421 |
|
|
Total
Value |
$7,078,410 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
5
|
Stock
price went up :
|
1
|
3
|
Stock
price went down : |
4
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
-23.4%
|
62.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Global Commercial... |
2005-06-30 |
24,133 |
2004-08-03 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Business Of... |
2012-07-02 |
59,030 |
2006-04-28 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2022-05-11 |
146,919 |
2021-11-05 |
19,500 |
Premium* |
|
Acer Therapeutics Inc |
ACER |
Director |
2023-11-17 |
0 |
2017-09-19 |
0 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2024-05-24 |
63,339 |
2024-05-24 |
2,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
170 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-04-01 |
4 |
AS |
$35.75 |
$29,024 |
D/D |
(805) |
32,034 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2008-04-30 |
4 |
B |
$10.37 |
$15,825 |
D/D |
1,526 |
33,560 |
2.74 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2008-05-02 |
4 |
S |
$37.75 |
$143,450 |
D/D |
(3,800) |
44,865 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2008-05-02 |
4 |
OE |
$7.16 |
$20,764 |
D/D |
2,900 |
36,460 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2008-05-06 |
4 |
S |
$37.75 |
$611,550 |
D/D |
(16,200) |
28,665 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev. |
|
2008-05-06 |
4 |
OE |
$7.16 |
$142,348 |
D/D |
12,205 |
48,665 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-07-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
31,165 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2008-10-31 |
5 |
B |
$13.35 |
$16,506 |
D/D |
1,236 |
32,401 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2009-04-30 |
4 |
A |
$10.93 |
$16,560 |
D/D |
1,515 |
33,916 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Global Commercial Dev |
|
2009-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
45,916 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Business Officer |
|
2009-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
48,416 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Business Officer |
|
2009-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
50,916 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2009-10-31 |
5 |
B |
$11.60 |
$4,119 |
D/D |
355 |
51,271 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-02 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
41,271 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-03 |
4 |
S |
$21.00 |
$210,000 |
D/D |
(10,000) |
31,271 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-04 |
4 |
S |
$21.50 |
$107,500 |
D/D |
(5,000) |
50,361 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-05 |
4 |
S |
$21.95 |
$140,831 |
D/D |
(6,416) |
43,945 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-08 |
4 |
OE |
$7.16 |
$172,484 |
D/D |
24,090 |
55,361 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-03-08 |
4 |
S |
$22.11 |
$532,526 |
D/D |
(24,090) |
19,855 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-04-30 |
4 |
A |
$11.64 |
$17,827 |
D/D |
1,532 |
21,387 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-05-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,200 |
32,587 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-05-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
35,087 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
37,587 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-09-08 |
4 |
OE |
$11.74 |
$410,900 |
D/D |
35,000 |
72,587 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Business Officer |
|
2010-09-08 |
4 |
S |
$22.00 |
$770,000 |
D/D |
(35,000) |
37,587 |
0 |
- |
|
170 Records found
|
|
Page 2 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|